Generics

The companies announced a partnership to streamline pricing alignment and ensure first-time charge-back accuracy on the MediLedger Blockchain Network.

Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.

The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products and a pipeline of seven additional products.

Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years.

Alkem Laboratories has appointed Madhurima Singh to its board as executive director for the next five years.

Vigabatrin is used to treat babies aged one month to 2 years old with infantile spasms.

Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make inexpensive versions of Merck’s COVID-19 pill molnupiravir, according to a report.

Colchicine tablets are indicated for prophylaxis and treatment of gout flares in adults and Familial Mediterranean fever in adults and children aged 4 years old and older.